21 unchanged sentences
December 2021 — $ — — $ 2,800.0
−Removed: Total 1,620,969 $ 246.77
−Removed: In October 2020 our Board of Directors authorized our 2020 Share Repurchase Program, which is a program to repurchase up to $5.0 billion of our common stock.
+Added: (1) There were no share repurchases during the fourth quarter of 2021.
+Added: In October 2020 our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2020 Share Repurchase Program).
Our 2020 Share Repurchase Program does not have an expiration date.
All share repurchases under our 2020 Share Repurchase Program will be retired.
−Removed: Under our 2020 Share Repurchase Program, we repurchased and retired approximately 1.6 million shares of our common stock at a cost of approximately $400.0 million during the year ended December 31, 2020.
+Added: Under our 2020 Share Repurchase Program, we repurchased and retired approximately 6.0 million and 1.6 million shares of our common stock at a cost of approximately $1.8 billion and $400.0 million during the years ended December 31, 2021 and 2020, respectively.
+Added: Approximately $2.8 billion remained available under our 2020 Share Repurchase Program as of December 31, 2021.
In December 2019 our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (December 2019 Share Repurchase Program), which was completed as of September 30, 2020.
6 unchanged sentences
All share repurchases under our 2018 Share Repurchase Program were retired.
−Removed: Under our 2018 Share Repurchase Program, we repurchased and retired approximately 8.9 million and 4.3 million shares of our common stock at a cost of approximately $2.1 billion and $1.4 billion during the years ended December 31, 2019 and 2018, respectively.
−Removed: In July 2016 our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2016 Share Repurchase Program), which was completed as of June 30, 2018.
−Removed: All share repurchases under our 2016 Share Repurchase Program were retired.
−Removed: Under our 2016 Share Repurchase Program, we repurchased and retired approximately 10.5 million shares of common stock at a cost of approximately $3.0 billion during the year ended December 31, 2018.
+Added: Under our 2018 Share Repurchase Program, we repurchased and retired approximately 8.9 million shares of our common stock at a cost of approximately $2.1 billion during the year ended December 31, 2019.
+Added: T a ble of Content s
Performance Graph
14 unchanged sentences
The information included under the heading Performance Graph is “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be “soliciting material” subject to Regulation 14A or incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.
−Removed: Selected Financial Data
−Removed: AND SUBSIDIARIES
−Removed: SELECTED FINANCIAL DATA
−Removed: Our results of operations are summarized as follows:
−Removed: For the Years Ended December 31,
−Removed: (In millions, except per share amounts) 2020 2019 2018 2017 2016
−Removed: Results of Operations
−Removed: Product revenues, net $ 10,692.2 $ 11,379.8 $ 10,886.8 $ 10,354.7 $ 9,817.9
−Removed: Revenues from anti-CD20 therapeutic programs 1,977.8 2,290.4 1,980.2 1,559.2 1,314.5
−Removed: Other revenues 774.6 707.7 585.9 360.0 316.4
−Removed: Total revenues 13,444.6 14,377.9 13,452.9 12,273.9 11,448.8
−Removed: Total cost and expenses 8,894.5 7,335.3 7,564.3 6,928.1 6,297.1
−Removed: Income from operations 4,550.1 7,042.6 5,888.6 5,345.8 5,151.7
−Removed: Other income (expense), net 497.4 83.3 11.0 (217.0) (218.7)
−Removed: Income before income tax expense and equity in loss of investee, net of tax 5,047.5 7,125.9 5,899.6 5,128.8 4,933.0
−Removed: Income tax expense 992.3 1,158.0 1,425.6 2,458.7 1,237.3
−Removed: Equity in loss of investee, net of tax (5.3) 79.4 — — —
−Removed: Net income 4,060.5 5,888.5 4,474.0 2,670.1 3,695.7
−Removed: Net income (loss) attributable to noncontrolling interests, net of tax 59.9 — 43.3 131.0 (7.1)
−Removed: Net income attributable to Biogen Inc.
−Removed: $ 4,000.6 $ 5,888.5 $ 4,430.7 $ 2,539.1 $ 3,702.8
−Removed: Diluted Earnings Per Share
−Removed: Diluted earnings per share attributable to Biogen Inc.
−Removed: $ 24.80 $ 31.42 $ 21.58 $ 11.92 $ 16.93
−Removed: Weighted-average shares used in calculating diluted earnings per share attributable to Biogen Inc.
−Removed: 161.3 187.4 205.3 213.0 218.8
−Removed: Our financial condition is summarized as follows:
−Removed: As of December 31,
−Removed: (In millions) 2020 2019 2018 2017 2016
−Removed: Financial Condition
−Removed: Cash, cash equivalents and marketable securities $ 3,382.2 $ 5,884.0 $ 4,913.9 $ 6,746.3 $ 7,724.5
−Removed: Total assets $ 24,618.9 $ 27,234.3 $ 25,288.9 $ 23,652.6 $ 22,876.8
−Removed: Notes payable, less current portion $ 7,426.2 $ 4,459.0 $ 5,936.5 $ 5,935.0 $ 6,512.7
−Removed: Total Biogen Inc.
−Removed: shareholders’ equity $ 10,700.3 $ 13,343.2 $ 13,039.6 $ 12,612.8 $ 12,140.1
−Removed: The financial data included within the tables above should be read in conjunction with our consolidated financial statements and related notes and Item 7.
−Removed: Management’s Discussion and Analysis of Financial Condition and Results of Operations included in this report and our previously filed Annual Reports on Form 10-K.
+Added: T a ble of Content s
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.